Good morning, Jason Mast here filing in for Ed on this Christmas week. No coffee this morning — well, not yet — but rather some Yemeni Tea from a certain rapidly expanding New York haunt. It’s sweeter than my usual cup and warmer. Ten out of ten.
Anyway, here’s some news for you today. I know it’s not much, by way of a gift, but it’s all we have….
The White House unveiled its largest batch of drug pricing agreements, announcing deals with Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis, and Sanofi, STAT tells us. The companies agreed to lower Medicaid prices for certain drugs that are more expensive than other countries. Only three other drugmakers pressed by Trump have yet to announce pacts with the administration, though the companies that have made deals have not made substantial changes to their guidance to investors, suggesting they don’t believe these deals will impact their bottom line. At a White House signing ceremony Friday, Trump said he would take aim at health insurers next.
